Julie Stephens

Julie Stephens' work focuses on clinical and population-level research in breast cancer, examining how patient and tumor characteristics (such as hormone receptor status, race, obesity, and genomic risk scores like Oncotype DX) affect treatment decisions and outcomes such as chemotherapy response and survival. The research also extends to HPV-related cancers, including HPV education and prevention efforts and HPV's role in oral and pharyngeal cancers. Much of this work uses large clinical databases (such as the National Cancer Database and SEER) and clinical trial data to study real-world treatment patterns and disparities in cancer care.

Publication output has fluctuated over the last decade, with a peak in 2020, a dip in 2022, and a recent increase in 2025, averaging about 8 publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026